Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure by L. Ostergaard et al.
© 2014 Ostergaard et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Hypoxia 2014:2 143–151
Hypoxia Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
143
O r i g i n a l  r e s e a r c H
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/HP.S57894
arginine-vasopressin marker copeptin is a 
sensitive plasma surrogate of hypoxic exposure
louise Ostergaard1,2,*
alain rudiger3,*
sven Wellmann2,4,5
elena gammella6
Beatrice Beck-schimmer2,3
Joachim struck7
Marco Maggiorini2,8
Max gassmann1,2,9
1institute of Veterinary Physiology, 
Vetsuisse Faculty, University of 
Zürich, 2Zürich center for integrative 
Human Physiology, 3institute of 
anesthesiology, 4Division of 
neonatology, University Hospital 
Zürich, Zürich, 5Department of 
neonatology, University children’s 
Hospital Basel, Basel, switzerland; 
6Department of Human Morphology 
and Biomedical science, University 
of Milan, Milan, italy; 7research 
Department, B⋅r⋅a⋅H⋅M⋅s Biomarkers, 
Thermo Fisher scientific, Hennigsdorf, 
germany; 8Medical intensive care 
Unit, University Hospital Zürich, 
Zürich, switzerland; 9Universidad 
Peruana cayetano Heredia, lima, Peru
*These authors contributed equally to 
this work and share first authorship
correspondence: l Ostergaard 
institute of Veterinary Physiology, 
Vetsuisse Faculty, University of Zürich, 
Winterthurerstrasse 260, 8057 Zürich, 
switzerland 
Tel +41 44 635 8807 
Fax +41 44 635 8932 
email ost@access.uzh.ch
Background: A reduced oxygen supply puts patients at risk of tissue hypoxia, organ damage, 
and even death. In response, several changes are activated that allow for at least partial adapta-
tion, thereby increasing the chances of survival. We aimed to investigate whether the arginine 
vasopressin marker, copeptin, can be used as a marker of the degree of acclimatization/adapta-
tion in rats exposed to hypoxia.
Methods: Sprague-Dawley rats were exposed to 10% oxygen for up to 48 hours. Arterial and 
right ventricular pressures were measured, and blood gas analysis was performed at set time 
points. Pulmonary changes were investigated by bronchoalveolar lavage, wet and dry weight 
measurements, and lung histology. Using a newly developed specific rat copeptin luminescence 
immunoassay, the regulation of vasopressin in response to hypoxia was studied, as was atrial 
natriuretic peptide (ANP) by detecting mid-regional proANP.
Results: With a decreasing oxygen supply, the rats rapidly became cyanotic and inactive. Despite 
continued exposure to 10% oxygen, all animals recuperated within 16 hours and ultimately 
survived. Their systemic blood pressure fell with acute (5 minutes) hypoxia but was partially 
recovered over time. In contrast, right ventricular pressures increased with acute (5 minutes) 
hypoxia and normalized after 16 hours. No signs of pulmonary inflammation or edema were 
found despite prolonged hypoxia. Whereas copeptin levels increased significantly after acute 
(5 minutes) hypoxia and then returned to near baseline after 16 hours, mid-regional proANP 
levels were even further increased after 16 hours of exposure to hypoxia.
Conclusion: Plasma copeptin is a sensitive marker of acute (5 minutes) exposure to severe 
hypoxia, and subsequent regulation can indicate recovery. Copeptin levels can therefore reflect 
clinical and physiological changes in response to hypoxia and indicate recovery from ongoing 
hypoxic exposure.
Keywords: vasoactive peptides, hypoxia, copeptin, atrial natriuretic peptide, acclimatization, 
adaptation, critical illness
Introduction
Low oxygen availability (eg, during perinatal asphyxia or exposure to high altitude) 
or impaired oxygen uptake (eg, due to acute respiratory distress syndrome in the 
critically ill) cause hypoxemia and physiological stress. The reaction to this potentially 
life-threatening situation requires both acute physiological changes as well as hypoxia-
dependent gene regulation, which induce a variety of specific adaptation mechanisms 
that ensure survival at cellular and systemic levels.1,2 Various reactions and adaptation 
mechanisms have been described, including increased ventilation, decreased metabolic 
rate, right shift of the hemoglobin dissociation curve, and bicarbonate ion secretion,3,4 
which are species-specific to some extent.5
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Arteries of the systemic circulation dilate in response to 
hypoxia to transport as much oxygen as possible to hypoxic 
tissues. In contrast, arteries of the pulmonary circulation 
constrict to optimize the match between ventilation and 
perfusion. This functional change in vascular tone increases 
the pulmonary pressures.6 Because pulmonary vasocon-
striction can be inhomogeneous, some lung areas become 
overperfused, which can cause pulmonary edema. This 
phenomenon has been described in mountaineers after rapid 
ascent to high altitudes, and is termed high altitude pulmonary 
edema, which is characterized by the development of protein-
rich pulmonary edema.7 An important pulmonary vasodilat-
ing factor is atrial natriuretic peptide (ANP), which has been 
shown to reduce pulmonary arterial pressure, whereas it does 
not exert a significant effect on the systemic circulation.8
Cardiorespiratory adaptation to hypoxia involves the 
neuroendocrine system. Direct neuronal projections to the 
spinal cord, brainstem, and sites that control cardiorespi-
ratory function increase ventilation (both tidal volume 
and frequency) and blood pressure (both heart rate and 
sympathetic nerve activity). Arginine vasopressin (AVP), 
a pituitary-secreted nonapeptide, reflects the stress response 
of the neuroendocrine system. Hypoxia can augment strong 
AVP release within a short time in various animal models.9–13 
AVP is unstable, making its detection cumbersome; however, 
its secretion can be estimated by measuring copeptin, the 
C-terminal portion of the AVP precursor, which is released 
in an equimolar ratio to AVP.14
The objective of this study was to characterize the physi-
ological response to acute versus prolonged hypoxia, with a 
focus on changes in plasma copeptin levels. This research will 
provide knowledge regarding the use of copeptin as a marker 
for hypoxic stress and the ensuing acclimatization.
Materials and methods
Hypoxic incubation of rats
All experiments were performed according to protocols 
approved by the local veterinary office (178/2008). Male 
Sprague-Dawley rats (Charles River Laboratories, Sulzfeld, 
Germany) were allowed to settle into a new environment for 
a week before exposure to hypoxia. The rats were placed 
in a hypoxic tent (Coy Laboratories, Grass Lake Charter 
 Township, MI, USA) with free access to food and water 
for up to 48 hours. The tent was large enough for two cages 
containing four animals each. The oxygen content inside the 
tent was gradually decreased by insufflation of nitrogen from 
room air (21%) to achieve a level of 10% O
2
 within one hour. 
This condition mimics an altitude of almost 6,000 m above 
sea level.15 Control animals were kept in room air. Due to 
the size of the tent, no CO
2
 accumulation was detected. For 
the initial experiments, the rats were exposed to hypoxia for 
8, 16, 24, and 48 hours; however, only minor changes were 
observed after 16 hours. Thus, the 16-hour time point was 
chosen for further evaluation.
HiF-1α immunoblotting
After 16 hours of hypoxia, the rats were anesthetized inside 
the hypoxic tent using an intraperitoneal injection of ketamine 
200 mg/kg (Vétoquinol AG, Ittigen, Switzerland) and xyla-
zine 20 mg/kg (Streuli Pharma AG, Uznach, Switzerland). 
The liver was rapidly excised and stored in liquid nitrogen. 
Liver tissue was homogenized in lysis buffer (10 mM Tris-
HCl [pH 8], 1 mM ethylenediaminetetraacetic acid [EDTA, 
pH 8], 400 mM NaCl, 0.1% NP-40, 1 mM dithiothreitol, 
1 mM phenylmethylsulfonyl fluoride, 1 mM orthovanadate, 
and protease inhibitor cocktail; Sigma-Aldrich, St Louis, 
MO, USA) and centrifuged for 10 minutes at 16,000× g. 
The proteins were separated by denaturing sodium dodecyl 
sulfate polyacrylamide gel electrophoresis, and after transfer 
to nitrocellulose, the membranes were blocked in 5% milk 
in phosphate-buffered saline for one hour at room tempera-
ture. Antibodies against hypoxia-inducible factor (HIF)-1α 
(NB 100–479, 1:1,000; Novus Biologicals, Littleton, CO, 
USA) were allowed to bind overnight at 4°C. The membrane 
was incubated with a horseradish peroxidase-conjugated 
secondary antibody for one hour at room temperature and 
then developed using chemiluminescent detection.
Hemodynamic measurements
The animals were transferred from the hypoxic tent to the 
bench in a plexiglass box, which was filled with isoflurane for 
induction of anesthesia. Isoflurane anesthesia was then pro-
vided via face mask. The oxygen concentration (either 10% 
or 21%) was maintained throughout using a custom-made 
anesthetic apparatus (Provet AG, Lyssach, Switzerland). 
The left carotid artery was dissected and cannulated with 
0.58 × 0.19 mm Portex tubing (Scientific Laboratory Supplies 
Ltd, Hessle, UK) for systemic blood pressure measurements. 
A 2.2 F microtip pressure catheter (Model SPR-249 Mikro-
Tip®, Millar Instruments, Houston, TX, USA) was inserted 
in the right internal jugular vein and advanced under pres-
sure guidance into the right ventricle. After instrumentation, 
the isoflurane dose was reduced to 1.5%. Hemodynamic 
measurements were recorded with a Power Lab system 
(ADInstruments Ltd, Oxford, UK) and analyzed with Chart 
7 software (ADInstruments Ltd). All pressures were taken 
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Figure 1 experimental timeline. after 16 hours of either normoxia or hypoxia, 
the animals were anesthetized and instrumented, and the systolic right ventricular 
pressure was measured at the following points: 1, normoxia at baseline; 2, acute 
hypoxia; 3, 16 hours of hypoxia; 4, recovery (normoxia, hyperoxia and hypoxia, with 
measurements as indicated in minutes). While the animals were under anesthesia, 
the inspired gas mixture was adjusted as illustrated, and blood was collected at the 
indicated time points. 
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); Hyp, hyperoxia (100% O2); 
hr, hours.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
145
copeptin as a sensitive hypoxic marker
at end of expiration. Arterial blood was drawn at set time 
points for automated blood gas analysis (ABL 800 Flex, 
Radiometer Medical ApS, Brønshøj, Denmark) and measure-
ment of copeptin and mid-regional proANP (see below). The 
experimental timeline is summarized in Figure 1.
Histology
The animals were anesthetized after 16 hours of hypoxia 
while still inside the tent with an intraperitoneal injection of 
ketamine 200 mg/kg (Vétoquinol AG) and xylazine 20 mg/kg 
(Streuli Pharma AG). The organs were removed, placed in 4% 
formalin for 24 hours, and embedded in paraffin blocks. Slices 
(5 µm) were cut and stained with hematoxylin and eosin.
lung and heart weights
Hearts and lungs were harvested from the animals for the 
HIF-1α experiments and rinsed. The right ventricle was 
carefully dissected, while the septum remained with the left 
ventricle. The lungs were heat-dried at 70°C for 48 hours, and 
weights were obtained before and after the procedure.
Bronchoalveolar lavage
Separate animals were anesthetized after 16 hours of hypoxia 
with an intraperitoneal injection of ketamine 200 mg/kg 
(Vétoquinol AG) and xylazine 20 mg/kg (Streuli Pharma 
AG). The animals were exsanguinated via an incision in 
the inferior vena cava, and the pulmonary circulation was 
perfused with ice-cold phosphate-buffered saline. Ice-cold 
phosphate-buffered saline (10 mL) was slowly instilled into 
and removed from the bronchoalveolar system five times via 
a tracheostomy. Total protein content was measured using the 
Bradford protein assay (Bio-Rad Laboratories, Inc., Hercules, 
CA, USA), whereas albumin was measured with a specific 
enzyme-linked immunosorbent assay kit (Bethyl Laboratories, 
Inc., Montgomery, TX, USA). The number of cells in the 
bronchoalveolar lavage fluid was evaluated by staining with 
trypan blue and counting in a Neubauer chamber.
Plasma copeptin and mid-regional 
proanP assay
After collecting blood into EDTA tubes, the samples were 
centrifuged, and the plasma was transferred to a new EDTA 
tube and subsequently frozen at −28°C. Measurement of 
plasma copeptin was performed in a single batch with a 
research sandwich immunoluminometric assay (C-terminal 
pro-AVP luminescence immunoassay; B⋅R⋅A⋅H⋅M⋅S GmbH, 
Hennigsdorf, Germany). Because the assay was developed 
for the detection of human plasma copeptin,14 it was not 
sufficiently cross-reactive with rat plasma copeptin. Thus, 
the tracer antibody of the assay was replaced with a purified 
sheep antibody developed against a peptide corresponding 
to amino acid positions 156–168 of rat pre-pro-vasopressin. 
Dilutions of a peptide corresponding to amino acid positions 
136–168 of rat pre-pro-vasopressin were used as calibrators. 
All other assay conditions were the same as those described 
for the human copeptin assay. Mid-regional proANP in 
plasma was measured with a commercial assay, which was 
originally designed for measuring human mid-regional 
proANP (KRYPTOR MR-proANP; B⋅R⋅A⋅H⋅M⋅S GmbH) 
according to the manufacturer’s instructions.
Data analysis
The data are expressed as the mean ± standard deviation of 
the indicated number of observations. Statistical comparisons 
between groups were performed with the Student’s t-test or 
one-way analysis of variance (Newman – Keuls post-test), as 
appropriate. Differences were considered to be statistically 
significant at P,0.05.
Results
Observations after 16 hours  
of hypoxic exposure
With decreasing oxygen content inside the tent, the rats 
became progressively lethargic. When the oxygen concentra-
tion reached 10%, the animals were resting motionless, using 
their efforts only for deep breathing. The rats had paused 
eating/drinking and stopped grooming. Their skin color had 
turned cyanotic, which was most visible at the animals’ ears 
and tails. However, the condition of the animals improved 
over the following hours. They started eating/drinking 
and grooming again and resumed their social interactions. 
Hypoxia 2014:2
−12
*
#
−10
−8
−6
−4
−2
0
2
Hx
Nx 24 hr
8 hr 16 hr 24 hr 48 hr
 
∆ 
w
ei
g
h
t 
(%
) 
Figure 2 Body weight gradually decreased with 8–24 hours of hypoxia, after which 
no further changes were observed. Weight loss is reported as a percentage by 
comparing the weight of the animal at the beginning of the experiment with that at 
the end. *P,0.05 versus normoxia at 24 hours; #P,0.05 versus hypoxia at 8 hours.
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); hr, hours.
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Figure 3 stabilization of HiF-1α in liver homogenates. representative immunoblot 
of a normoxic control (first lane) compared with three hypoxic (16 hours) samples 
(lanes 2–4). all hypoxic liver samples (n=6) showed stabilization of HiF-1α. 
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); HiF-1α, hypoxia-
inducible factor-1α; h, hours.
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After 16 hours of hypoxia, the behavior of the rats had 
normalized, although the animals were still cyanotic. 
 During the following observation period of up to 48 hours 
of hypoxia, no relevant changes in physical appearance, 
behavior, or other parameters were noted. Importantly, all 
animals survived the prolonged hypoxic exposure. At base-
line, the animals weighed 293±3.9 g. After 8 and 16 hours of 
hypoxia, the animals had lost 6.2%±0.14% and 8.1%±0.67% 
(P,0.05) of their body weight, respectively (Figure 2). 
 However, the decline in body weight stopped after 16 hours, 
and body weight remained similar thereafter until the end of 
the 48-hour observation period.
stabilization of HiF-1α in the liver
To verify that the animals were indeed reacting to the hypoxic 
conditions, stabilization of the transcription factor, HIF-1α, 
was verified in liver protein extracts from both hypoxic 
(16 hours) and normoxic animals (Figure 3).
systemic and pulmonary hemodynamics
Hemodynamic changes are shown in Table 1. Systemic 
blood pressure dropped significantly with acute (5 minutes) 
hypoxia but was partially normalized after 16 hours of 
hypoxia. Of note, systemic pulse pressure (ie, the difference 
between systolic and diastolic blood pressure) increased 
significantly with acute (5 minutes) hypoxia, whereas the 
heart rate dropped transiently. Respiration rate increased sig-
nificantly with decreasing oxygen availability and remained 
slightly but not significantly elevated until the end of the 
hypoxic episode. Changes in right ventricular pressures 
are shown in Figure 4. Baseline values (28.6±0.8 mmHg) 
increased to 46.0±6.4 mmHg after acute (5 minutes) hypoxic 
exposure. After 16 hours of exposure to 10% oxygen, the 
pressure was again similar to baseline (31.0±1.4 mmHg), 
and with normoxic recovery, no further alteration was 
observed (29.6±2.1 mmHg). Peak right ventricular pres-
sure, a surrogate for systolic pulmonary artery pressure, 
was significantly increased with acute (5 minutes) hypoxia. 
However, the pressures normalized over time, and the values 
at 16 hours were similar to those at baseline. End-diastolic 
right ventricular pressures did not change significantly over 
time (data not shown). In addition, we calculated the right 
ventricle to total heart weight ratio and found no significant 
changes (data not shown).
arterial blood gas analysis
The results of arterial blood gas analysis are shown in Table 2. 
The decrease in oxygen availability was paralleled by a per-
sistently low arterial oxygen concentration (paO
2
). However, 
with normalization of the ambient oxygen concentration, 
paO
2
 normalized immediately. The evident hyperventilation 
resulted in low arterial concentrations of CO
2
 during the 
hypoxic episode. Of note, pCO
2
 remained low despite normal-
ization of the inspiratory oxygen content. In addition, hypoxia 
led to an increase in lactate levels and metabolic acidosis.
no evidence of pulmonary  
edema in hypoxic lungs
Histological examination of rat lungs stained with hema-
toxylin and eosin did not reveal formation of edema (data 
not shown). An increase in the wet lung to body weight ratio 
from baseline to 8 hours of hypoxic exposure was observed 
(P,0.05), and this was further augmented after 16–48 hours. 
However, the lung dry to wet weight ratio at 16 hours of 
hypoxia was similar to that in normoxic control animals 
(Figure 5). In addition, no changes in right ventricular mass 
were detected (data not shown).
Hypoxia 2014:2
Table 1 systemic hemodynamics
Nx, baseline Hx, 5 min Hx, 16 hr Nx, recovery
Heart rate (1/min) 365 (±66) 267 (±36)#,* 346 (±51) 365 (±33)
systolic blood pressure (mmHg) 96 (±16.5)* 70 (±7.3)#,* 83 (6.8)# 116 (±13.6)#,*
Mean arterial pressure (mmHg) 80 (±16.3)* 46 (±4.4)#,* 65 (±9.3)# 96 (±10.0)#,*
Diastolic blood pressure (mmHg) 72 (±16.4)* 34 (±4.4)#,* 56 (±11.6)# 87 (±9.1)#,*
respiratory rate (1/min) 60 (±8.2) 77 (±14.5)# 68 (±9.0) 55 (±12.2)
systemic pulse pressure (mmHg) 25 (±6.1) 36 (±6.7)* 27 (±9.5) 30 (±8.3)
Notes: #P,0.05 compared to nx baseline; *P,0.05 compared to Hx, 16 hr. n=7–8.
Abbreviations: nx, normoxia; Hx, hypoxia; hr, hours; min, minutes.
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Figure 4 systolic right ventricular pressure (srVP) measured by right heart cathe-
terization. Two separate experiments were performed, in which rats were exposed to 
16 hours of ambient room air (baseline) followed by an acute hypoxic phase (5 minutes) 
or 16 hours of hypoxia followed by a normoxic recovery phase. *P,0.05, n=7. 
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); rV, right ventricular; 
min, minutes; hr, hours.
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no increase in constituents  
of bronchoalveolar lavage fluid
Total protein concentration, albumin content, and number 
of cells was measured in the bronchoalveolar lavage fluid of 
hypoxic lungs and normoxic lungs (Figure 6). We observed 
no change in the amount of total protein (data not shown), 
whereas a decrease in albumin was observed after hypoxia 
(7,253±1,151 µg/µL and 4,647±431 µg/µL, normoxic and 
hypoxic values, respectively; P=0.049). Further, the number 
of cells in the extracted fluid was slightly reduced, although 
this was not significant.
changes in copeptin and  
mid-regional proanP plasma levels
Plasma levels of copeptin were measured under control 
(normoxic) conditions and after acute exposure to 10% 
oxygen (5 minutes), which caused an almost seven-fold 
increase (Figure 7). After 16 hours of hypoxia, the values 
had returned to baseline, and no further modification was 
observed when switching acutely to normoxia (5 minutes) or 
hyperoxia (10 minutes). When the animal was re-exposed to 
hypoxia for 5 and 10 minutes, the initial increase in copeptin 
was reproduced. On the other hand, mid-regional proANP 
exhibited a small increase upon acute (5 minutes) hypoxic 
exposure, which was further augmented after 16 hours of 
hypoxia. This increase was attenuated gradually upon return 
to normoxic conditions, resulting in baseline values after one 
hour. Exposure to hyperoxia had no effect, nor did repeated 
exposure to acute hypoxia (5 and 10 minutes).
Discussion
Here, we present evidence that acute (5 minutes) hypoxia 
leads to profound physiological changes in vivo, which are 
paralleled by a strong increase in copeptin levels, indicating 
activation of the AVP system. Despite ongoing exposure to 
hypoxia (10% ambient oxygen, 16 hours), the rats eventu-
ally recovered and resumed their normal activities, albeit 
to a somewhat lesser degree. Recovery was mirrored by a 
normalization of plasma copeptin levels.
A consistent reduction in body weight over time was 
observed in hypoxic rats. This result can be explained by 
the decreased fluid and food intake in the first hours after the 
onset of hypoxia. In addition, fluid loss was most likely aggra-
vated by increased water vapor loss due to hyperventilation. 
The degree of intravascular fluid deficit was mirrored by an 
increase in hematocrit measured at 16 hours of hypoxia, as 
this hemoconcentration is most likely not a result of increased 
hematopoiesis at this early time point.
As the animals adapted to hypoxic exposure, ongoing 
cellular hypoxia was verified by investigating stabilization of 
the oxygen-sensitive transcription factor, HIF-1α. This tran-
scription factor was confirmed in liver homogenates from all 
hypoxic animals, whereas only very low levels were observed 
in normoxic animals. We therefore conclude that the exposure 
of the rats to 10% oxygen did in fact result in tissue and cellular 
hypoxia at 16 hours. This conclusion was further supported by 
an increase in lactate levels and severe metabolic acidosis; the 
persistent hyperventilation despite normalization of the ambient 
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Figure 5 Fluid accumulation in the lungs was assessed by two approaches. (A) The wet lung to body weight ratio was calculated after 8, 16, 24, and 48 hours of hypoxia 
(*P,0.05). (#P,0.05 for difference between 8 hours and 16 hours of hypoxia). (B) The wet to dry lung ratio was measured at baseline and after 16 hours of hypoxia, n=6. 
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); hr, hours.
Table 2 arterial blood gas analysis
Nx, baseline Hx, 5 min Hx, 16 hr Nx, recovery
paO2 (mmHg) 95 (±8.9)* 39 (±4.7)# 43 (± 8.3)# 110 (±15.4)#,*
pcO2 (mmHg) 40 (±4.2)* 34 (±2.3)#,* 25 (±4.2)# 29 (±5.1)#,*
saO2 (%) 92 (±2.1)* 56 (±8.3)# 57 (±15.2)# 94 (±2.4)*
Hemoglobin (g/dl) 14.3 (±1.1)* 13.1 (±0.6)#,* 15.5 (±1.9)# 15.0 (±0.4)
Hematocrit (%) 44.0 (±3.3)* 40.1 (±1.8)#,* 47.9 (±0.7)# 45.9 (±1.1)
glucose (mmol/l) 14.1 (±1.6) 13.6 (±2.3) 14.3 (±1.7) 12.8 (±1.5)
lactate (mmol/l) 1.1 (±0.2)* 3.9 (±0.2)#,* 2.3 (±0.4)# 2.4 (±0.4)#
pH 7.41 (±0.05) 7.44 (±0.02) 7.47 (±0.05) 7.41 (±0.05)
Base excess (mmol) 0.53 (±1.3)* −0.71 (±0.8)* −5.35 (±2.5)# −5.65 (±2.5)#
HcO3
− (mmol/l) 24.8 (±1.5)* 23.3 (±0.7)* 20.4 (±1.9)# 20.5 (±1.9)#
Notes: #P,0.05 compared to nx, baseline; *P,0.05 compared to Hx, 16 hr. n=6–8.
Abbreviations: paO2, arterial oxygen tension; pcO2, carbondioxide tension; saO2, arterial oxygen saturation; HcO3
−, bicarbonate; nx, normoxia; Hx, hypoxia; min, 
minutes; hr, hours.
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oxygen concentration most likely represents an effort to com-
pensate for these issues. Notably, the animals appeared to be 
unperturbed despite these severe metabolic disturbances.
Acute (5 minutes) hypoxia induced significant systemic 
hypotension, which was partially normalized after 16 hours. 
The systemic diastolic blood pressure decreased even more 
than the systolic pressure. This observation can be explained 
by hypoxia-induced vasodilatation.16 The fact that the pulse 
pressure was higher in hypoxic animals suggests that stroke 
volume was maintained, if not increased, in hypoxic rats, and 
a low left ventricular afterload might have contributed to this 
phenomenon. An increase in stroke volume might at least 
partially explain the significant drop in heart rate observed 
during acute (5 minutes) hypoxia. Another explanation 
might be the activation of an autonomic reflex in response to 
severe hypoxia, as can be found in patients with asphyxia.17 
Future investigations, including blood flow measurements, 
are needed to resolve this intriguing finding of transient 
hypoxia-induced bradycardia.
As expected, we observed an acute hypoxic vasoconstric-
tive response in the pulmonary circulation after 5 minutes of 
breathing 10% oxygen, resulting in an elevated systolic right 
ventricular pressure. When measuring the same parameter 
again after 16 hours, pressures had returned to those observed 
with normoxia. Given that ANP was increased with hypoxia, 
it is likely that this hormone is involved in adaptation or 
normalization of the pulmonary arterial pressure after pro-
longed exposure to hypoxia. It has previously been reported 
that ANP has an effect on subacute but not acute hypoxic 
exposures18 and that ANP levels are only slightly elevated 
after short exposures to hypoxia,19 which is in agreement 
with our findings.
We measured the plasma levels of the AVP surrogate 
marker copeptin to determine the hypoxia-specific neuroen-
docrine stress response. It is well established that hyperos-
molarity causes an approximately 5-fold increase in plasma 
copeptin concentrations,20 whereas acute cardiovascular 
disease and sepsis augment plasma copeptin concentrations 
up to 20-fold.21 The strongest copeptin increase has been 
found at birth in naturally delivered newborns,22 which is 
in agreement with our data, as contractions during delivery 
cause brief acute fetal hypoxia/ischemia. Thus far, only one 
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10 minutes of hyperoxia (100% oxygen), or repeated exposure to hypoxia for 5 and 10 minutes. (A) Plasma copeptin (pmol/l). (B) Plasma sodium (mM). (C) Plasma mid-
regional proanP (pmol/l). *P,0.05 versus normoxia (baseline); #P,0.05 versus repeated acute hypoxia (5 minutes), n=5. 
Abbreviations: nx, normoxia (21% O2); Hx, hypoxia (10% O2); Hyp, hyperoxia (100% O2); hr, hours; m, minutes; proanP, proatrial natriuretic peptide; 
Mr, mid-regional.
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study has investigated plasma copeptin in vivo by applying an 
infant ventilation model in Wistar rats. Copeptin was reported 
to be increased by 10-fold in response to hypoxemia and 
other stressful conditions.23 In the study presented here, we 
aimed to closely examine the acute versus prolonged AVP/
copeptin response to hypoxia in the context of hemodynamic 
changes. AVP triggers adaptive responses in the kidney, 
vasculature, and other organs. For example, AVP mediates 
acute hypoxia-induced antidiuresis as investigated in dogs.11 
Of note, AVP released upon acute hypoxia has been sug-
gested to affect the kidney and lungs in llama fetuses (more 
so than those in sheep fetuses).24 Our data indicate that it is 
the acute decrease in paO
2
 causing AVP/copeptin release. 
However, we cannot exclude the possibility that, instead of 
a direct effect of hypoxia signaling on AVP/copeptin release 
which may integrate the autonomic nervous system,25 an 
indirect mechanism may be involved. Based on our own 
data (Figure 4) and those published previously,26 acute 
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hypoxia results in a sudden drop of systolic blood pressure in 
rodents. Acute arterial hypotension is a well known trigger of 
AVP/copeptin release, for which reason both possible links 
between acute hypoxia and AVP/copeptin release, direct or 
indirect, might be involved.
As noted above, prolonged (16 hours) hypoxia did lead to 
a reduction in body weight but not to a significant increase in 
sodium levels or copeptin levels as shown in Figure 7. Hence, 
it can be concluded that dehydration, as a known trigger 
of AVP/copeptin release,20 was not present after 16 hours 
of hypoxia. In addition, the rats showed clinical signs of 
anorexia in the first hours after the onset of hypoxia, including 
decreased fluid and food intake. It has been suggested that 
anorexia impairs osmoregulation of AVP27 and may affect 
copeptin levels after 16 hours of hypoxia, but it is unlikely 
that it affects copeptin levels within the very short time of 
5 minutes of hypoxia.
There are several indications that hypoxia-induced pulmo-
nary edema did not develop in our animal model. First, arterial 
oxygen content did not progressively worsen with a longer 
duration of hypoxia. Second, arterial oxygen tension was nor-
malized immediately when the animals were breathing room 
air again. Third, lung weights did not increase significantly 
when corrected for body weight. Fourth, no edema fluid was 
detectable with light histology. Fifth, no increase in albumin 
concentrations or cell counts was observed in fluids isolated 
from bronchoalveolar lavage. Together, our results are in 
contrast with previous papers demonstrating hypoxia-induced 
pulmonary edema in rats.28,29 This discrepancy might be 
explained by the different genetic backgrounds of the research 
animals used. Other potential explanations include use of 
normobaric hypoxia instead of hypobaric normoxia30–32 and 
the lack of physical exercise in our animals.33 More research 
is needed to resolve these conflicting results.
limitations of the study
We limited our mechanistic studies of prolonged hypoxia to 
the time point of 16 hours, because our observations in a pilot 
study suggested that there were no significant pathophysi-
ological changes beyond this time point. Clearly, a much 
longer duration of hypoxia (eg, several weeks) might have 
revealed additional findings; however, the effects of chronic 
hypoxia were outside the scope of this study.  Kelestimur 
et al34 showed that plasma AVP values gradually increased 
after 4 weeks of hypoxia. This finding could indicate a bipha-
sic response, although it should be noted that the reported 
increase is significantly lower than what we observed in the 
acute phase. Another important point is the fact that the 
hypoxic exposure was intermittent, because the cages were 
opened every other day. This intermittent exposure would 
also add cumulative stress to the animals.
Conclusion and clinical perspectives
Acute (5 minutes) hypoxia led to profound physiological 
changes, paralleled by a strong increase in copeptin levels. 
Despite ongoing exposure to 10% oxygen, the animals even-
tually recovered. This recovery was paralleled by normaliza-
tion of plasma copeptin levels. Hence, plasma copeptin is 
a strong and sensitive marker of acute exposure to severe 
hypoxia, and at the same time, lack of induction indicates 
recovery. Copeptin can therefore reflect the ability of the 
organism to adapt to severe hypoxia.
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